Roundup Cancer Lawsuit Update

Roundup lawsuit MDL reaches second year in U.S. District Court

Monday, October 23, 2017 - The Roundup lawsuit multidistrict litigation has reached its second year of pretrial proceedings as of October of 2017. The case, Roundup Products Liability Litigation (MDL No. 2741) consists of hundreds of plaintiffs filing suit against Monsanto on the basis of allegations of Roundup cancer. Specifically, plaintiffs in Roundup lawsuits assert they were not warned of the risk of cancer from Roundup exposure including non-Hodgkin‘s lymphoma.

While Monsanto officials persist in refuting Roundup cancer allegations, global public health entities and many nations have issued Roundup cancer warnings. The first major Roundup cancer warning was issued by the World Health Organization‘s International Agency for Research on Cancer (IARC) in 2015. The WHO classifies carcinogens by degrees; Roundup was classified is a ‘probable‘ carcinogen, meaning there is evidence to support the statement that developing cancer from Roundup is likely possible.

Research shows that persons who have been exposed to Roundup for as little as eight hours experience higher incidence rates of non-Hodgkin‘s lymphoma, multiple myeloma, and leukemia. The presence of glyphosate in Roundup and similar herbicides is blamed for higher cancer rates. Both those who have directly used Roundup and those who have been exposed to it environmentally are thought to be at risk for developing Roundup cancer.

Several evolutions have occurred in the Roundup lawsuit MDL over the past year. What started as twenty-one plaintiffs has snowballed into hundreds of Roundup cancer claims against the global agriculture giant. Initially proposed for consolidation in Illinois, pretrial proceedings for Roundup cancer lawsuits are currently underway in U.S. District Court in the Northern District of California. While Monsanto initially opposed centralization of Roundup cancer claims, the California district was the company‘s preferred location for consolidation.

The Roundup lawsuit cases have several items on the schedule as the process moves toward trial this autumn and winter in U.S. District Court. Expert witness testimony is scheduled to begin on December 11, 2017. Shortly thereafter, summary judgment is scheduled for November 15.

Monsanto officials persist in denying any connection between Roundup and cancer, despite the existence of many global studies showing otherwise. Some experts allege that Monsanto has long been aware of the Roundup cancer risk yet has withheld warning information from the public.

As legal proceedings advance, new Roundup lawsuits are still being consolidated with the Roundup lawsuit MDL. Plaintiffs from anywhere in the United States who were diagnosed with cancer after using Roundup may qualify to file a claim. If you or a loved one has been diagnosed with a form of cancer (including multiple myeloma, leukemia, non-Hodgkin‘s lymphoma, or another form of cancer) following exposure to Roundup, you may be entitled to compensation through filing a Roundup cancer lawsuit.

Our Roundup lawyers are providing no-cost, no-obligation case review to persons and family members of persons who believe they may have grounds for a roundup lawsuit against Monsanto. Contact our firm for an evaluation with a Roundup cancer attorney today.

Information Provided by The Onder Law Firm

The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O‘Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm‘s attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Other Roundup Lawsuit Attorney News Releases: